Intracoronary Stenting and Antithrombotic Regimen: Testing of a Six-Week Versus a Six-Month Clopidogrel Treatment Regimen in Patients With Concomitant Aspirin and Oral Anticoagulant Therapy Following Drug-Eluting Stenting.

Trial Profile

Intracoronary Stenting and Antithrombotic Regimen: Testing of a Six-Week Versus a Six-Month Clopidogrel Treatment Regimen in Patients With Concomitant Aspirin and Oral Anticoagulant Therapy Following Drug-Eluting Stenting.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs Clopidogrel (Primary) ; Anticoagulants; Aspirin
  • Indications Coronary stent thrombosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms ISAR-TRIPLE
  • Most Recent Events

    • 25 Nov 2013 Planned end date changed from 1 Dec 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov.
    • 21 Nov 2013 Planned end date changed from 1 Jul 2012 to 1 Dec 2014 as reported by ClinicalTrials.gov record.
    • 16 Jan 2012 Updated purpose and added treatment table.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top